Fitbit creates wearable for activity tracking in children

Cara Livernois | | Health Exec | Precision Medicine

Fitbit, the popular manufacturer of wireless-enabled wearable technology devices, has announced the development of fitness trackers for children.

The obesity epidemic in America is affecting both adults and children. In response to the growing healthcare costs, Fitbit is introducing fitness trackers for children with the goal of improving activity levels and decision-making before weight becomes a problem.

The wearables function much like the current Fitbits on the market by counting steps, tracking sleep and providing reminders to move. But they also offer parents the ability to track their children’s activity though a mobile family account. The app will also allow for fitness goals to be set. Fitbit also notes the device is compliant with the Children’s Online Privacy Protection Act (COPPA) to ensure privacy security.

Read the full story below:

Fitbit is launching a fitness tracker for kids

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.